Bernice Welles

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA.

Enject, Inc. engaged in drug development. The company was founded in 2007 and was headquartered in Battle Ground, WA.

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA.

The San Francisco Food Bank collects, sorts, inspects, repackages and distributes food. The company was founded in 1987 and is headquartered in San Francisco, CA.

American Life Science Pharmaceutical, Inc. engages in developing small molecule drugs for treating neurodegenerative disease. It initially focuses on TBI and Alzheimer''s disease. The company was founded by Gregory Hook and Vivian Hook in 2002 and is headquartered in La Jolla, CA.